TechnologiesTechnologiesTechnologiesTechnologies
  • Home
  • Company
    • Our Vision
    • History
    • Current State
    • Contact
  • R&D Projects
    • Anti aging research
    • Mitochondrial transfer technology
    • Anticancer vaccine research
  • Technologies
    • Cancer Immunotherapy
    • Autoimmune and Allergic Disorders Immunotherapy
    • Chronic Inflammatory Diseases Immunotherapy
    • OPI Therapy for Motor and Skin Diseases
    • Storage of Immune Cells
  • R&D Products
    • Cord blood plasma
    • Mesenchymal Stem Cells
    • Exosomes
    • Polyantigenic anticancer vaccine
    • Cell lines
    • Cell-based Products
  • Clinic
  • EU projects
  • News
✕

Technologies

  • Home
  • Technologies

Innovita Research has developed some experimental technologies that can be provided for scientific and other customers. In many cases we can help with the preparation and application of these technologies under customer local governmental rules/requirements.

  • Cancer immunotherapy
  • T-cell immunotherapy (T-cell vaccination) for autoimmune and allergic disorders
  • Adoptive cell-based immunotherapy for chronic inflammatory diseases
  • OPI therapy for motor and skin diseases
  • Storage of immune cells

Related science news

  • Personalized mRNA Cancer Vaccines Cut Recurrence Risk by Half After Five Years
    January 22, 2026
  • Chemists determine the structure of the fuzzy coat that surrounds Tau proteins
    January 22, 2026
  • Researchers build new antibody to target cancer cells
    January 21, 2026
  • Intraoperative Tumor Histology May Enable More-Effective Cancer Surgeries
    January 16, 2026
  • New discovery in cancer signaling reveals a potential path to more effective cancer drugs
    January 15, 2026
More news.
© 2017 - 2026 Innovita Research | Privacy policy